BACKGROUND/AIMS: Recent studies have implicated a region on chromosome 1q21-23, including the NOS1AP gene, in susceptibility to schizophrenia. However, replication studies have been inconsistent, a fact that could partly relate to the marked psychopathological heterogeneity of schizophrenia. The aim of this study is to evaluate association of polymorphisms in the NOS1AP gene region to schizophrenia, in patients from a South American population isolate, and to assess if these variants are associated with specific clinical dimensions of the disorder. METHODS: We genotyped 24 densely spaced SNPs in the NOS1AP gene region in a schizophrenia trio sample. The transmission disequilibrium test (TDT) was applied to single marker and haplotype data. Association to clinical dimensions (identified by factor analysis) was evaluated using a quantitative transmission disequilibrium test (QTDT). RESULTS: We found significant association between eight SNPs in the NOS1AP gene region to schizophrenia (minimum p value = 0.004). The QTDT analysis of clinical dimensions revealed an association to a dimension consisting mainly of negative symptoms (minimum p value 0.001). CONCLUSIONS: Our findings are consistent with a role for NOS1AP in susceptibility to schizophrenia, especially for the 'negative syndrome' of the disorder.
BACKGROUND/AIMS: Recent studies have implicated a region on chromosome 1q21-23, including the NOS1AP gene, in susceptibility to schizophrenia. However, replication studies have been inconsistent, a fact that could partly relate to the marked psychopathological heterogeneity of schizophrenia. The aim of this study is to evaluate association of polymorphisms in the NOS1AP gene region to schizophrenia, in patients from a South American population isolate, and to assess if these variants are associated with specific clinical dimensions of the disorder. METHODS: We genotyped 24 densely spaced SNPs in the NOS1AP gene region in a schizophrenia trio sample. The transmission disequilibrium test (TDT) was applied to single marker and haplotype data. Association to clinical dimensions (identified by factor analysis) was evaluated using a quantitative transmission disequilibrium test (QTDT). RESULTS: We found significant association between eight SNPs in the NOS1AP gene region to schizophrenia (minimum p value = 0.004). The QTDT analysis of clinical dimensions revealed an association to a dimension consisting mainly of negative symptoms (minimum p value 0.001). CONCLUSIONS: Our findings are consistent with a role for NOS1AP in susceptibility to schizophrenia, especially for the 'negative syndrome' of the disorder.
Authors: E Lindholm; B Ekholm; S Shaw; P Jalonen; G Johansson; U Pettersson; R Sherrington; R Adolfsson; E Jazin Journal: Am J Hum Genet Date: 2001-05-25 Impact factor: 11.025
Authors: R E Straub; C J MacLean; Y Ma; B T Webb; M V Myakishev; C Harris-Kerr; B Wormley; H Sadek; B Kadambi; F A O'Neill; D Walsh; K S Kendler Journal: Mol Psychiatry Date: 2002 Impact factor: 15.992
Authors: Ana Miranda; Jenny García; Carlos López; Derek Gordon; Carlos Palacio; Gabriel Restrepo; Juan Ortiz; Gabriel Montoya; Carlos Cardeño; Jorge Calle; María López; Omer Campo; Gabriel Bedoya; Andrés Ruiz-Linares; Jorge Ospina-Duque Journal: Schizophr Res Date: 2005-12-20 Impact factor: 4.939
Authors: Luis G Carvajal-Carmona; Roel Ophoff; Susan Service; Jaana Hartiala; Julio Molina; Pedro Leon; Jorge Ospina; Gabriel Bedoya; Nelson Freimer; Andrés Ruiz-Linares Journal: Hum Genet Date: 2003-02-25 Impact factor: 4.132
Authors: Carlos Alberto Palacio; Jenny García; María Patricia Arbeláez; Ricardo Sánchez; Beatriz Aguirre; Isabel Cristina Garcés; Gabriel Jaime Montoya; Juliana Gómez; Angela Agudelo; Carlos Alberto López; Jorge Julián Calle; Carlos Alberto Cardeño; Juan Fernando Cano; María Cecilia López; Patricia Montoya; Claudia Patricia Herrera; Natalia González; Alejandro González; Gabriel Bedoya; Andrés Ruiz; Jorge Ospina Journal: Biomedica Date: 2004-03 Impact factor: 0.935
Authors: Linda M Brzustowicz; Jaime Simone; Paria Mohseni; Jared E Hayter; Kathleen A Hodgkinson; Eva W C Chow; Anne S Bassett Journal: Am J Hum Genet Date: 2004-04-02 Impact factor: 11.025
Authors: Cathryn M Lewis; Douglas F Levinson; Lesley H Wise; Lynn E DeLisi; Richard E Straub; Iiris Hovatta; Nigel M Williams; Sibylle G Schwab; Ann E Pulver; Stephen V Faraone; Linda M Brzustowicz; Charles A Kaufmann; David L Garver; Hugh M D Gurling; Eva Lindholm; Hilary Coon; Hans W Moises; William Byerley; Sarah H Shaw; Andrea Mesen; Robin Sherrington; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler; Jesper Ekelund; Tiina Paunio; Jouko Lönnqvist; Leena Peltonen; Michael C O'Donovan; Michael J Owen; Dieter B Wildenauer; Wolfgang Maier; Gerald Nestadt; Jean-Louis Blouin; Stylianos E Antonarakis; Bryan J Mowry; Jeremy M Silverman; Raymond R Crowe; C Robert Cloninger; Ming T Tsuang; Dolores Malaspina; Jill M Harkavy-Friedman; Dragan M Svrakic; Anne S Bassett; Jennifer Holcomb; Gursharan Kalsi; Andrew McQuillin; Jon Brynjolfson; Thordur Sigmundsson; Hannes Petursson; Elena Jazin; Tomas Zoëga; Tomas Helgason Journal: Am J Hum Genet Date: 2003-06-11 Impact factor: 11.025
Authors: Niamh X Cawley; William C Wetsel; Saravana R K Murthy; Joshua J Park; Karel Pacak; Y Peng Loh Journal: Endocr Rev Date: 2012-03-07 Impact factor: 19.871
Authors: Richard Delorme; Catalina Betancur; Isabelle Scheid; Henrik Anckarsäter; Pauline Chaste; Stéphane Jamain; Franck Schuroff; Gudrun Nygren; Evelyn Herbrecht; Anne Dumaine; Marie Christine Mouren; Maria Råstam; Marion Leboyer; Christopher Gillberg; Thomas Bourgeron Journal: BMC Med Genet Date: 2010-07-05 Impact factor: 2.103
Authors: Naomi S Wratten; Holly Memoli; Yungui Huang; Anna M Dulencin; Paul G Matteson; Michelle A Cornacchia; Marco A Azaro; Jaime Messenger; Jared E Hayter; Anne S Bassett; Steven Buyske; James H Millonig; Veronica J Vieland; Linda M Brzustowicz Journal: Am J Psychiatry Date: 2009-03-02 Impact factor: 18.112
Authors: Damien Carrel; Yangzhou Du; Daniel Komlos; Norell M Hadzimichalis; Munjin Kwon; Bo Wang; Linda M Brzustowicz; Bonnie L Firestein Journal: J Neurosci Date: 2009-06-24 Impact factor: 6.167
Authors: B Kremeyer; J García; H Müller; M W Burley; I Herzberg; M V Parra; C Duque; J Vega; P Montoya; M C López; G Bedoya; V Reus; C Palacio; C López; J Ospina-Duque; N B Freimer; A Ruiz-Linares Journal: Hum Hered Date: 2010-11-10 Impact factor: 0.444